The purpose of the study is to examine changes in muscle strength and self-reported physical functioning in men receiving androgen deprivation therapy (ADT) for prostate cancer compared to matched controls.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
Prostate cancer patients scheduled to begin ADT (n = 62) were assessed within 20 days of starting ADT and 6 and 12 months later. Age and geographically matched prostate cancer controls treated with prostatectomy only (n = 86) were assessed at similar time intervals. Grip strength measured upper body strength, the Chair Rise Test measured lower body strength, and the SF-12 Physical Functioning scale measured self-reported physical functioning.
As expected, self-reported physical functioning and upper body muscle strength declined in ADT recipients but remained stable in prostate cancer controls. Contrary to expectations, lower body muscle strength remained stable in ADT recipients but improved in prostate cancer controls. Higher Gleason scores, more medical comorbidities, and less exercise at baseline predicted greater declines in physical functioning in ADT recipients.
ADT is associated with declines in self-reported physical functioning and upper body muscle strength as well as worse lower body muscle strength relative to prostate cancer controls. These findings should be included in patient education regarding the risks and benefits of ADT. Findings also underscore the importance of conducting research on ways to prevent or reverse declines in physical functioning in this patient population.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2015 Nov 13 [Epub ahead of print]
Brian D Gonzalez, Heather S L Jim, Brent J Small, Steven K Sutton, Mayer N Fishman, Babu Zachariah, Randy V Heysek, Paul B Jacobsen
Division of Cancer Prevention and Control, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. , Health Outcomes and Behavior Program, Moffitt Cancer Center, 12902 Magnolia Drive MRC-ADMIN, Tampa, FL, 33612, USA. , School of Aging Studies, University of South Florida, Tampa, FL, USA. , Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA. , Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA. , Department of Radiation Oncology, James A. Haley Veterans' Hospital, Tampa, FL, USA. , Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA. , Health Outcomes and Behavior Program, Moffitt Cancer Center, 12902 Magnolia Drive MRC-ADMIN, Tampa, FL, 33612, USA.